Trial intelligence / Profile preview

Zonisamide add-on therapy in elderly patients with refractory partial seizures

2006-002516-10Phase 4Terminated

Sponsor
Eisai Co., Ltd.
Start
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in epilepsy comparing Zonisamide add-on with Placebo add-on (2 arms). Primary endpoints: Cognition and Sedation. Started Jul 2008; status: terminated.

02

Drugs

zonisamide
03

Conditions

epilepsy

Beyond the preview

Go deeper on 2006-002516-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002516-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call